73.74
price up icon21.38%   13.01
 
loading
Metsera Inc stock is traded at $73.74, with a volume of 8.15M. It is up +21.38% in the last 24 hours and up +42.03% over the past month. Metsera Inc is a clinical-stage biotechnology company developing next-generation injectable and oral nutrient-stimulated hormone (NuSH) analog peptides to treat obesity, overweight, and related conditions. The Company has developed and is implementing proprietary methods and platform technologies to advance a broad, scalable, and combinable portfolio of injectable and oral NuSH analog peptides with the potential to address not only the limitations of approved therapies but also many of the anticipated limitations of next-generation therapies in development. The Company uses its proprietary MINT peptide library of NuSH analog peptides alongside its Half-life Augmentation by Lipid Optimization half-life extending platform.
See More
Previous Close:
$60.73
Open:
$68.9
24h Volume:
8.15M
Relative Volume:
3.51
Market Cap:
$7.74B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+40.62%
1M Performance:
+42.03%
6M Performance:
+187.39%
1Y Performance:
+0.00%
1-Day Range:
Value
$68.00
$74.00
1-Week Range:
Value
$51.92
$74.00
52-Week Range:
Value
$12.30
$74.00

Metsera Inc Stock (MTSR) Company Profile

Name
Name
Metsera Inc
Name
Phone
(212) 784-6595
Name
Address
3 WORLD TRADE CENTER, NEW YORK
Name
Employee
109
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
MTSR's Discussions on Twitter

Compare MTSR with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MTSR
Metsera Inc
73.72 6.39B 0 0 0 0.00
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.16 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
629.15 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
424.92 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
837.09 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
184.56 39.72B 447.02M -1.18B -868.57M -6.1812

Metsera Inc Stock (MTSR) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-30-25 Downgrade Wells Fargo Overweight → Equal Weight
Sep-09-25 Initiated Leerink Partners Outperform
Jun-20-25 Initiated Wells Fargo Overweight
Feb-25-25 Initiated BofA Securities Buy
Feb-25-25 Initiated Evercore ISI Outperform
Feb-25-25 Initiated Guggenheim Buy
View All

Metsera Inc Stock (MTSR) Latest News

pulisher
01:47 AM

Novo Nordisk Outbids Pfizer In $10 Billion Metsera Takeover Battle - Finimize

01:47 AM
pulisher
01:35 AM

Novo Nordisk Is Still Beating Pfizer in Battle Over Metsera - Barron's

01:35 AM
pulisher
01:31 AM

Palantir, Hertz, Metsera, Uber, DraftKings: Stocks Making The Biggest Moves Today - Stocktwits

01:31 AM
pulisher
01:30 AM

Teneo Refs Bidding War for Metsera - O'Dwyer's PR

01:30 AM
pulisher
01:28 AM

Novo, Pfizer Boost Metsera Bids in Obesity Startup Battle - MarketScreener

01:28 AM
pulisher
01:04 AM

Pfizer Metsera Lawsuit - Buffalo News

01:04 AM
pulisher
01:02 AM

M&A News: Novo Nordisk Stock (NVO) Slides after Increasing Its Metsera Offer to $10B - TipRanks

01:02 AM
pulisher
12:48 PM

Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera By Reuters - Investing.com

12:48 PM
pulisher
12:43 PM

Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo - WTAQ

12:43 PM
pulisher
12:27 PM

Novo Nordisk hikes Metsera bid to up to $10B in competition with rival Pfizer - WFMZ.com

12:27 PM
pulisher
12:24 PM

Novo Nordisk tops Pfizer in bidding war for obesity startup Metsera - Proactive financial news

12:24 PM
pulisher
12:15 PM

Pfizer, Novo Nordisk escalate bidding war for obesity drug developer Metsera - Reuters

12:15 PM
pulisher
12:15 PM

Metsera’s Shares Spike Amid Acquisition Proposals from Novo Nordisk and Pfizer - StocksToTrade

12:15 PM
pulisher
12:00 PM

Takeover Saga for Obesity Drugmaker Metsera Heats Up - Bloomberg

12:00 PM
pulisher
11:55 AM

Metsera rises after Novo Nordisk and Pfizer sweeten bids - TradingView

11:55 AM
pulisher
11:53 AM

Novo Nordisk (NVO) Raises Bid to Acquire Metsera, Outbidding Pfi - GuruFocus

11:53 AM
pulisher
11:50 AM

Delaware court won't rule on Pfizer/Novo battle for Metsera today - Seeking Alpha

11:50 AM
pulisher
11:42 AM

Delaware judge does not see current need for court in Metsera bidding war between Pfizer and Novo By Reuters - Investing.com

11:42 AM
pulisher
11:40 AM

Novo Sweetens Its Bid For Metsera, Pledging Up To $10 Billion - Investor's Business Daily

11:40 AM
pulisher
11:27 AM

Pfizer Fields Novo’s $10B Curveball, With Bourla Promising To Fight for Metsera - BioSpace

11:27 AM
pulisher
11:23 AM

Novo Nordisk, Pfizer sweeten bid for Metsera as bidding war heats up - Yahoo Finance

11:23 AM
pulisher
11:22 AM

Metsera Considers Novo Nordisk’s Superior Acquisition Proposal - TipRanks

11:22 AM
pulisher
11:17 AM

Novo Nordisk’s (NVO) $9B Metsera Bid Sparks Showdown with Archrival Pfizer (PFE) - TipRanks

11:17 AM
pulisher
11:03 AM

Metsera receives amended ‘superior’ proposal from Novo Nordisk - TipRanks

11:03 AM
pulisher
11:02 AM

Metsera saga continues, with upped bids from Novo and Pfizer - The Pharma Letter

11:02 AM
pulisher
11:01 AM

Pfizer, Novo Nordisk Escalate Bidding War for Weight-Loss Drug Startup - The Wall Street Journal

11:01 AM
pulisher
10:59 AM

Pfizer & Novo boost Metsera bids, Hertz stock skyrockets - Yahoo Finance

10:59 AM
pulisher
10:55 AM

Metsera Inc Declares Novo Nordisk Proposal Superior - TradingView

10:55 AM
pulisher
10:53 AM

Metsera Gets 'Superior' Acquisition Bid From Novo Nordisk, Challenging Pfizer Merger - MarketScreener

10:53 AM
pulisher
10:47 AM

Pfizer, Novo Boost Bids for Obesity Drugmaker Metsera in Takeover Saga - Bloomberg.com

10:47 AM
pulisher
10:38 AM

Novo Nordisk Hikes Metsera Bid to up to $10B in Competition With Rival Pfizer - U.S. News & World Report

10:38 AM
pulisher
10:37 AM

Novo Nordisk (NVO) Extends Enhanced Acquisition Offer for Metser - GuruFocus

10:37 AM
pulisher
10:23 AM

/C O R R E C T I O N -- Metsera, Inc./ - Placera.se

10:23 AM
pulisher
10:21 AM

Novo Nordisk CEO faces baptism of fire amid board shakeup, Pfizer fight - Reuters

10:21 AM
pulisher
10:20 AM

NVO's Acquisition Offer Values Metsera at $10B - GuruFocus

10:20 AM
pulisher
10:18 AM

Novo, Pfizer's bidding war heats up with supercharged offers for Metsera - Fierce Biotech

10:18 AM
pulisher
10:18 AM

Pfizer, Novo Nordisk improve offers for Metsera as bidding war escalates - Capital Brief

10:18 AM
pulisher
10:15 AM

Metsera, Inc. Stock Soars Amid Acquisition Drama - TipRanks

10:15 AM
pulisher
10:13 AM

Metsera Receives Amended Proposal from Novo Nordisk - citybiz

10:13 AM
pulisher
10:08 AM

Novo Nordisk (NVO) Offers Enhanced Proposal to Metsera - GuruFocus

10:08 AM
pulisher
10:07 AM

Novo Nordisk and Pfizer sweeten bids for Metsera - Axios

10:07 AM
pulisher
10:05 AM

Novo Ups Ante In Metsera Buyout Drama With $10B Offer, Beating Pfizer’s New Bid - BioSpace

10:05 AM
pulisher
10:02 AM

Metsera stock soars as Novo Nordisk, Pfizer sweeten bids in takeover battle - Investing.com

10:02 AM
pulisher
09:58 AM

Novo Nordisk Sweetens Offer for Metsera - The Wall Street Journal

09:58 AM
pulisher
09:56 AM

Pfizer Boosts Profit View While Chasing Obesity Startup Metsera - Bloomberg

09:56 AM
pulisher
09:48 AM

Bidding war between Pfizer, Novo Nordisk for obesity startup Metsera escalates - statnews.com

09:48 AM
pulisher
09:44 AM

Novo Nordisk submits updated proposal to acquire Metsera - MarketScreener

09:44 AM
pulisher
09:40 AM

Metsera Gets Revised Bids From Pfizer, Novo Nordisk: Here’s Why It Matters - Stocktwits

09:40 AM
pulisher
09:35 AM

Metsera says Novo Nordisk’s new up to $10 billion bid for obesity drugmaker is ‘superior’ to revised Pfizer offer - CNBC

09:35 AM
pulisher
09:34 AM

Novo Nordisk submits updated proposal to acquire Metsera, Inc. - The Manila Times

09:34 AM
pulisher
09:31 AM

Both Novo Nordisk and Pfizer have adjusted their bids for Metsera. - MarketScreener

09:31 AM

Metsera Inc Stock (MTSR) Financials Data

There is no financial data for Metsera Inc (MTSR). Check out other stocks for more information.

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.75
price up icon 1.25%
$28.95
price up icon 0.84%
$102.27
price up icon 0.89%
$104.59
price up icon 0.62%
biotechnology ONC
$312.21
price up icon 0.08%
$184.87
price down icon 0.68%
Cap:     |  Volume (24h):